DYSIS View is de nieuwste colposcoop die de DYSISmap™ bevat en de gegevens genereert die professionele zorgverleners kunnen helpen om cervicale laesies duidelijker te detecteren

ATLANTA–(BUSINESS WIRE)– DYSIS Medical Inc. is verheugd om de lancering aan te kondigen van DYSIS®View, een compacte en draagbare colposcoop, die de innovatieve computerondersteunde cervicale kaarttechnologie van het bedrijf omvat die beroepsbeoefenaren in de gezondheidszorg helpt om cervicale laesies duidelijker te detecteren.

Dit persbericht bevat multimedia. Bekijk de volledige release hier: https://www.businesswire.com/news/home/20210727005846/en/

De DYSIS-familie van colposcopen omvat de nieuwe DYSISmap, een kleurgecodeerde samenvatting van het acetowhitening-effect van de baarmoederhals van de patiënt. Kleuren worden op de kaart toegewezen, afhankelijk van de veranderingen in acetowhitening gemeten door DYSIS tijdens het onderzoek. Deze gegevens helpen beroepsbeoefenaren in de gezondheidszorg de biopsieselectie te verbeteren. In de IMPROVE-COLPO-studie, toen kaart ondersteunde biopsieën werden toegevoegd aan colposcopie-onderzoeken, nam de detectie van patiënten met CIN2+ toe met 44%.

DYSIS Announces New Compact and Portable Colposcope Design with Computer-Aided Cervical Mapping

DYSIS View is the newest colposcope that includes the DYSISmap™ and generates the data that can help healthcare professionals detect cervical lesions more clearly

ATLANTA–(BUSINESS WIRE)– DYSIS Medical Inc. is excited to announce the launch of DYSIS^® View, a compact and portable colposcope, which includes the company’s innovative computer-aided cervical mapping technology that helps healthcare professionals detect cervical lesions more clearly.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005846/en/

DYSIS View | Computer-Aided Colposcopy with Cervical Mapping (Photo: Business Wire)

The DYSIS family of colposcopes include the novel DYSISmap, which is a color-coded summary of the acetowhitening effect of the patient’s cervix. Colors are allocated on the map depending on the acetowhitening changes measured by DYSIS during the examination. This data helps healthcare professionals improve biopsy selection. In the IMPROVE-COLPO study, when map-assisted biopsies were added to colposcopy exams, detection of patients with CIN2+ increased by 44%¹.

“We are thrilled to bring DYSIS View to market to complement our already strong presence with DYSIS Ultra,” said Darin Hammers, CEO of DYSIS Medical. “While DYSIS View is much more compact and portable than our previous colposcope designs, it’s equal in sophistication and technology. It fills a gap in the market where we’re able to provide our innovative mapping technology to a wide range of healthcare professionals.”

In addition to the innovative cervical mapping technology, DYSIS View includes a camera for high resolution exam videos and images, instant replay of colposcopy exams, DYSIS SMARTtrack™ to compare a patient’s DYSIS View colposcopy exams and a patient database for record storage. Find out more about the new DYSIS View colposcope at dysismedical.com.

About DYSIS Medical

DYSIS Medical Inc. is based in Atlanta, Georgia. The Company is committed to early detection and diagnosis of cervical disease using biophotonic innovations. DYSIS is committed to becoming the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications. For more information, please visit dysismedical.com.

¹DeNardis et al. Int J Womens Health. 2017; 9: 717–725.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005846/en/

Contacts

Brent Palmisano

770-847-8482

brent.palmisano@dysismedical.com